Home > Press Releases > Pharmaceutical Leadership for Daiichi Sankyo

Afterburner, Inc. Teams with Daiichi Sankyo's Pharmaceutical Leadership Team to Execute American Market Strategy

Afterburner Selected to Implement Flawless Execution Training Development Program

Atlanta, GA - January 11, 2011 - Afterburner, Inc., a leading team building, training, and consulting firm and the global authority on the Flawless Execution model, has been selected by Daiichi Sankyo, Inc., the U.S. subsidiary of the major top-twenty global pharmaceutical company Daiichi Sankyo Co., Ltd., to train its pharmaceutical leadership team in the Flawless Execution strategy. Based in Tokyo, Daiichi has a presence in Europe and Asia, and is further expanding in the American market. Afterburner will implement a training development program to assist the company as it enters the market.

A 100-year-old organization, Daiichi Sankyo currently maintains the most European affiliates of any Japanese pharmaceutical company. Looking to expand beyond its current market, the company viewed America as ideal for its rapid expansion. Daiichi Sankyo determined that it would seize the opportunity that the American market presented, and looked to Afterburner to work with Daiichi's existing pharmaceutical leadership team to deliver the Flawless Execution training development program.

"We are pleased that Daiichi Sankyo, Inc. has selected Afterburner to assist in its American market strategy, and has recognized the value that the Flawless Execution method delivers to corporate performance - both nationally and internationally," said Jim "Murph" Murphy, founder and CEO of Afterburner. "We are engaging in an in-depth training development program encompassing the entire pharmaceutical leadership team, and plan to visit the company's sites across the U.S. until we have delivered Flawless Execution training to the entire group." To learn more about how Afterburner Equip's consulting services can help your company expand through new markets, please visit www.afterburnerconsulting.com.

About Afterburner Equip

Afterburner Inc., founded in 1996 by Jim "Murph" Murphy, a U.S. Air Force fighter pilot who realized the value of the tools he learned in the 'zero tolerance for error' world of military aviation, has trained over 1.5 million managers and executives in the simple, scalable improvement processes of Flawless Execution. Within this model is its Equip solution, which provides training, consulting, and software services through a variety of methods. With a client list that includes over 23% of the U.S. Fortune 500 companies, Afterburner has been featured regularly in publications such as the Wall Street Journal, Business Week, Inc. Magazine, Financial Times, Newsweek, and Meetings and Conventions Magazine. In addition, the company has appeared on CNN, CNBC, Fox News, and Bloomberg News. For more information about the Equip program, please visit www.afterburnerconsulting.com.

About Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com. Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group. For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.


© Copyright 2009 Afterburner, Inc